Breaking News Instant updates and real-time market news.

PBYI

Puma Biotechnology

$95.70

-0.35 (-0.36%)

04:55
01/12/18
01/12
04:55
01/12/18
04:55

Puma Biotechnology says CHMP to discuss neratinib on January 23

Puma Biotechnology announced last night that it met with Europe's Committee for Medicinal Products for Human Use Scientific Advisory Group on Oncology. SAG was asked to provide an opinion on the clinical relevance of the five-year absolute treatment difference in invasive disease free survival seen in the Phase III ExteNET trial and on the risk of gastrointestinal toxicity with neratinib and its acceptability in the proposed patient population in the company's Marketing Authorization Application for neratinib, Puma said. Based on the feedback from SAG and the rapporteurs, the company intends to modify the summary of product characteristics, sometimes referred to as the European product label, in its MAA for neratinib to further refine the intended population to patients at a high risk of disease recurrence. Puma noted that CHMP will be conducting an oral hearing to discuss the MAA for neratinib on January 23, and that it has been invited to present the risk benefit profile of neratinib in the identified population at this meeting.

PBYI Puma Biotechnology
$95.70

-0.35 (-0.36%)

11/10/17
FBCO
11/10/17
NO CHANGE
Target $142
FBCO
Outperform
Puma Biotechnology launch meeting high expectations, says Credit Suisse
Credit Suisse analyst Alethia Young raised her price target for Puma Biotechnology shares to $142 from $136 saying she believes the Nerlynx launch is living up to high expectations. The analyst keeps an Outperform rating on Puma following the Q3 results.
12/14/17
SBSH
12/14/17
NO CHANGE
Target $164
SBSH
Buy
Citi sees positive CHMP opinion for Puma's neratinib
Citi analyst Yigal Nochomovitz says his analysis of drugs evaluated during European Medicines Agency Scientific Advisory Group meetings in oncology provides "unusually strong evidence" that Puma Biotechnology's neratinib is likely to receive a positive Committee for Medicinal Products for Human Use opinion. Puma yesterday announced that the EMA requested a Scientific Advisory Group provide an opinion on the clinical aspects of neratinib on January 11, 2018. The analyst identified 14 instances where the EMA convened a SAG in oncology, with 86% receiving a positive CHMP opinion. Further, 100% of tyrosine kinase inhibitors in the examples Nochomovitz identified received a positive CHMP opinion. He believes this reinforces his positive view on neratinib. The analyst has a Buy rating on Puma Biotechnology with a $164 price target.
12/18/17
LEER
12/18/17
NO CHANGE
LEER
Puma Biotechnology, Clovis top picks in biotech for 2018 at Leerink
Leerink analyst Michael Schmidt expects oncology to remain an attractive area within Biotech in 2018. Key product launches, a rich set of pivotal trial results, and pending regulatory decisions among stocks he covers make 2018 a catalyst-rich year, particularly in the first half of 2018, the analyst contends. Puma Biotechnology (PBYI) and Clovis (CLVS) are Schmidt's top-picks with Incyte (INCY) as a close third. Additionally, he sees ImmunoGen (IMGN) and Karyopharm (KPTI) as attractive emerging small-caps for 2018.
01/03/18
SBSH
01/03/18
NO CHANGE
Target $164
SBSH
Buy
Puma Biotechnology sold off on FDA database comments, says Citi
Citi analyst Yigal Nochomovitz attributes the 5% pullback yesterday in shares of Puma Biotechnology to a competing research firm highlighting that the FDA's Adverse Event Reporting System shows 137 adverse events and four deaths among patients receiving Nerlynx. The FAERS has "substantial limitations which FDA has publically acknowledged," Nochomovitz tells investors in a research note titled "Alert: Word to the Wise on Using FDA's Adverse Event Reporting." The analyst believes the FAERS data by themselves are not an indicator of the safety profile of a drug. He keeps a Buy rating on Puma with a $164 price target.

TODAY'S FREE FLY STORIES

FB

Facebook

$189.35

3.98 (2.15%)

16:50
01/23/18
01/23
16:50
01/23/18
16:50
Hot Stocks
Facebook acquires mobile ID authentication startup Confirm.io »

Confirm.io announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

ASB

Associated Banc-Corp

$25.90

-0.15 (-0.58%)

, BKMU

BankMutual

$10.85

-0.1 (-0.91%)

16:46
01/23/18
01/23
16:46
01/23/18
16:46
Hot Stocks
Associated receives regulatory approvals to acquire BankMutual »

Associated Banc-Corp…

ASB

Associated Banc-Corp

$25.90

-0.15 (-0.58%)

BKMU

BankMutual

$10.85

-0.1 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

DKL

Delek Logistics

$32.80

0.5 (1.55%)

16:46
01/23/18
01/23
16:46
01/23/18
16:46
Hot Stocks
Delek Logistics raises quarterly dividend by 1.4% to 72.5c »

Delek Logistics Partner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

NTIP

Network-1 Technologies

$2.60

0.1 (4.00%)

, GOOG

Alphabet

$1,169.97

14.16 (1.23%)

16:45
01/23/18
01/23
16:45
01/23/18
16:45
Hot Stocks
Network-1 Technologies receives favorable ruling from federal circuit court »

Network-1 Technologies…

NTIP

Network-1 Technologies

$2.60

0.1 (4.00%)

GOOG

Alphabet

$1,169.97

14.16 (1.23%)

GOOGL

Alphabet Class A

$1,176.17

12.01 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

SIGM

Sigma Designs

$7.00

0.025 (0.36%)

16:45
01/23/18
01/23
16:45
01/23/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Sigma Designs »

Sigma Designs trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$40.06

0.75 (1.91%)

16:44
01/23/18
01/23
16:44
01/23/18
16:44
Hot Stocks
U.S. Steel 'pleased' with Presidential tariffs on certain imports »

United States Steel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

UAL

United Continental

$77.97

1.1 (1.43%)

16:42
01/23/18
01/23
16:42
01/23/18
16:42
Hot Stocks
United Continental says 2017 a 'transition' year »

Says understands that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 21

    Mar

AUO

AU Optronics

$4.69

0.03 (0.64%)

16:42
01/23/18
01/23
16:42
01/23/18
16:42
Upgrade
AU Optronics rating change  »

AU Optronics upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGII

Argo Group

$65.10

0.05 (0.08%)

16:41
01/23/18
01/23
16:41
01/23/18
16:41
Hot Stocks
Argo Group reports preliminary pre-tax catastrophe loss of $34M-$38M in Q4 »

Argo Group International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGNX

MacroGenics

$20.25

0.83 (4.27%)

16:40
01/23/18
01/23
16:40
01/23/18
16:40
Hot Stocks
MacroGenics completes interim futility analysis of the Phase 3 SOPHIA trial »

MacroGenicsannounced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPL

LG Display

$15.59

1.33 (9.33%)

16:38
01/23/18
01/23
16:38
01/23/18
16:38
Upgrade
LG Display rating change  »

LG Display upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDS

GDS Holdings

$26.75

-0.22 (-0.82%)

16:37
01/23/18
01/23
16:37
01/23/18
16:37
Syndicate
Breaking Syndicate news story on GDS Holdings »

GDS Holdings files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:36
01/23/18
01/23
16:36
01/23/18
16:36
General news
API crude inventories for week of January 19 »

API reports that crude…

NAVI

Navient

$13.44

-0.08 (-0.59%)

16:34
01/23/18
01/23
16:34
01/23/18
16:34
Earnings
Breaking Earnings news story on Navient »

Navient reports Q4 GAAP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FHN

First Horizon

$20.11

0.01 (0.05%)

16:34
01/23/18
01/23
16:34
01/23/18
16:34
Hot Stocks
First Horizon replaces share repurchase program »

The board of First…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FHN

First Horizon

$20.11

0.01 (0.05%)

16:33
01/23/18
01/23
16:33
01/23/18
16:33
Hot Stocks
First Horizon increases quarterly dividend 33% »

First Horizon National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SD

SandRidge Energy

$19.29

-0.02 (-0.10%)

16:32
01/23/18
01/23
16:32
01/23/18
16:32
Hot Stocks
SandRidge Energy: Not in best interests of holders to accept Ichan's proposal »

SandRidge Energy issued a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CQP

Cheniere Energy Partners

$31.30

0.41 (1.33%)

16:32
01/23/18
01/23
16:32
01/23/18
16:32
Hot Stocks
Cheniere Energy Partners raises dividend to 50c from 44c »

Cheniere Energy Partners,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

GORO

Gold Resource

$4.97

0.05 (1.02%)

16:32
01/23/18
01/23
16:32
01/23/18
16:32
Hot Stocks
Gold Resource to expand Arista Mine vein system »

Gold Resource announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

TRMK

Trustmark

$33.53

-0.03 (-0.09%)

16:31
01/23/18
01/23
16:31
01/23/18
16:31
Earnings
Trustmark reports Q4 adjusted EPS 48c, consensus 47c »

Gerard R. Host, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

16:30
01/23/18
01/23
16:30
01/23/18
16:30
Options
Preliminary option volume of 22.5M today »

Preliminary option volume…

SBBP

Strongbridge Biopharma

$8.70

0.25 (2.96%)

16:27
01/23/18
01/23
16:27
01/23/18
16:27
Syndicate
Strongbridge Biopharma files to sell 5M shares of common stock »

JMP Securities is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$120.00

0.56 (0.47%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Technical Analysis
Technical Take: Texas Instruments drops sharply after results »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Hot Stocks
Breaking Hot Stocks news story on Capital One »

Capital One reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

JAX

J. Alexander's

$10.20

-0.3 (-2.86%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Hot Stocks
J. Alexander's major holders support 99 Restaurants acquisition »

Substantial holders of J.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.